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Fungi comprise a vast group of microorganisms including the Ascomycota (majority of all described fungi), the Basidiomycota
(mushrooms or higher fungi), and the Zygomycota and Chytridiomycota (basal or lower fungi) that produce industrially inter-
esting secondary metabolites, such as β-lactam antibiotics. These compounds are one of the most commonly prescribed drugs
world-wide. Since Fleming’s initial discovery of Penicillium notatum 80 years ago, the role of Penicillium as an antimicrobial source
becamepatent.Aftertheisolationof PenicilliumchrysogenumNRRL1951sixdecadesago,classicalmutagenesisandscreeningpro-
grams led to the development of industrial strains with increased productivity (at least three orders of magnitude). The new
“omics” era has provided the key to understand the underlying mechanisms of the industrial strain improvement process. The re-
view of diﬀerent proteomics methods applied to P. chrysogenum has revealed that industrial modiﬁcation of this microorganism
was a consequence of a careful rebalancing of several metabolic pathways. In addition, the secretome analysis of P. chrysogenum has
opened the door to new industrial applications for this versatile ﬁlamentous fungus.
1.Introduction:EvolutionofFungiin
PenicillinProduction
Life comprises three domains: the bacteria, the archaea, and
the eukaryota. Within the last one, the fungi kingdom forms
a monophyletic group of the eukaryotic crown group, which
collects the largest group of organisms [1]. Fungi consist of
a heterogeneous group including yeasts, moulds, and mush-
rooms characterized by their lack of photosynthetic pigment
and their chitinous cell wall [2]. Hawksworth and Rossman
[3, 4] described that the number of fungal species ranged
between 72,000 and 120,000, which supposes less than
10% of the theoretically estimated 1.5 million existing fun-
gal species. In contrast, when environmental samples based
on metagenomics data are evaluated, the species number
increases to as high as 3.5 million [5]. The discovery of the
new fungal species described along the last years was evaluat-
ed by Hibbett and coworkers [6], which averages 223 species
peryear,mostlyAscomycota.Thesedatapresentahugenum-
ber of unrecognized and unidentiﬁed fungal species (more
than 90%), which could be discovered in associations with
plants, insects, and animals, as lichen-forming fungi or in
undisturbed areas [4].
Traditionally, the four main fungal phyla were Ascomy-
cota (majority of all described fungi) and Basidiomycota,
which embody the mushrooms or higher fungi, and the Zyg-
omycota and Chytridiomycota, which represent the basal or
lower fungi. The ﬁrst three phyla theoretically diverged from
the last one (Chytridiomycota) approximately 550 million
years ago [1, 7, 8]. This was an evolutionary step previous
to the land invasion of the plants. The fungal taxonomy is in
continuous movement; thus, Zygomycota has been replaced
byseveralsubphyla[9],andthearbuscularmycorrhizalfungi
Glomeromycota has been included as a new phylum [10].
This evolution of the fungi and fungal-like microorganisms
can be observed in the complex phylogenetic tree based on a
Bayesian inference analysis reviewed by Voigt and Kirk [8].
The fungal environmental impact is remarkable due to
the central role played in the organic matter decomposition
process because of their ability to degrade recalcitrant com-
pounds such as lignin; thereby the organic material utiliza-
tion is enhanced by the microbial community. In addition,2 Journal of Biomedicine and Biotechnology
some species are involved in disease interactions with hu-
mans, plants, or animals, either by means of their direct
action as disease agents or through the production of secon-
dary metabolites (e.g., host-speciﬁc toxins). Related to this,
ﬁlamentousfungiproduceadiversearrayofsecondarymeta-
bolites and enzymes [11], which have a tremendous impact
on society because they are exploited for their antibiotic
(penicillins, cephalosporins, etc.) or pharmaceutical (cyclo-
sporin and other immunosuppressants) activities and their
industrial applications in white biotechnology (beverage
industries). Therefore, fungi are the second most important
group (after Actinobacteria) of secondary metabolites pro-
ducers with industrial application [12].
Amongsecondarymetabolites,antibiotics(andmorepre-
cisely β-lactam antibiotics) are especially relevant. The dis-
covery of β-lactam antibiotics is one of the most signiﬁcant
milestones of the human history and entailed a revolution in
modern chemotheraphy. Members of this family of antibi-
otics are commonly prescribed due to their high activity and
lowtoxicityandhavehelpedmedicinetoreducedramatically
the mortality rate. The history of these compounds started
up in 1928 after Sir Alexander Fleming’s accidental discovery
of the antimicrobial activity generated by a fungus culture
contaminating a Petri dish cultured with Staphylococcus sp.
Fleming, who worked at the St. Mary’s Hospital in London,
initiallyidentiﬁedthemouldresponsiblefortheantibacterial
eﬀect as Penicillium rubrum [13]. However, it was not until
1932 when the Fleming’s isolate was correctly identiﬁed as
Penicillium notatum and the active compound inhibiting the
bacterial growth was dubbed penicillin [14]. Fleming did
not extend his work to clinical study due to the low amounts
and instability of the penicillin puriﬁed from culture broths.
It was in 1940 when a group of workers from the Sir Will-
iam Dunn School of Pathology at Oxford University (H. W.
F l o r e y ,E .B .C h a i n ,N .H e a t l e y ,C .M .F l e t c h e r ,A .D .G a r -
dner, M. A. Jennings, J. Orr-Ewing, A. G. Sanders, and E.
Abraham) were able to undertake detailed studies on peni-
cillin [15]. However, massive production could not be
accomplished in England due to World War II. Therefore,
Florey and Heatley went to the United States in June 1941
and convinced the U.S. Department of Agriculture (USDA)
and several pharmaceutical ﬁrms (Charles Pﬁzer and Co., E.
R. Squibb and Sons, and Merck and Co., among others) to
produce penicillin [16]. Heatley remained for a period at the
Northern Regional Research Laboratory of the USDA, Peo-
ria, Illinois, USA. The isolation of new strains of Penicillium
chrysogenum, industrial improvement programs (see below),
andmediummodiﬁcationsfavoredthedevelopmentofpeni-
cillin high-producing strains. The tremendous cooperative
eﬀort among universities and industrial laboratories in En-
gland and the United States during the war led to multiple
large-scale clinical trials to treat those wounded in battle in
England and in the United States during 1942 and 1943 [16].
In 1945, Ernst B. Chain, Howard W. Florey, and Sir Alex-
ander Fleming were awarded with the Nobel Prize for Physi-
ology and Medicine. A year later, penicillin was ﬁnally avail-
able in the open market.
Since the early days of penicillin development, it was
rather clear that several diﬀerent penicillins were being
produced,dependingonthecompositionofthemedium,the
fungal strain, and the fermentation conditions. Penicillins
containabicyclic“penam”nucleusformedbyfusedβ-lactam
and sulphur-containing thiazolidine rings and an acyl side
chain bound to the amino group at C-6. The side chain de-
pends on the precursors present in the culture medium. Side
chainattachmentisrelativelynonspeciﬁc,andtherefore,nat-
ural penicillins, such as penicillin F (3-hexenoic as side
chain), and K (octanoic acid as side chain), are synthesized
under natural conditions. However, feeding the cultivation
media with phenylacetic or phenoxyacetic acids directs the
biosynthesis mainly towards benzylpenicillin (penicillin G)
or phenoxymethylpenicillin (penicillin V), respectively. Bio-
synthesis, regulation, and evolution of the penicillin pathway
have been reviewed extensively [17–19].
Another important milestone that opened a new era of
chemotherapy was the detection and isolation of 6-amino-
penicillanic acid (6-APA) in fermented broths in the decade
of 1950s [20–23]. This penicillin precursor is the basis of
semisyntheticpenicillins,whichareachievedthroughthead-
dition of diﬀerent side chains to 6-APA by a chemical process
[24].
2. ClassicalStrainImprovementand
Molecular Genomic-TranscriptomicBasis of
theIncreasedPenicillinProductivity
One of the main problems that researchers initially had to
face was the low penicillin titers (about 2 i.u. (international
units)/mL or 1.2μg/mL) produced by the original Fleming’s
P. notatum strain (NRRL 1249B21). This, together with the
increasing demand of antibiotics derived from World War II
and subsequent conﬂicts during the 20th century, led scien-
tists to isolate new strains with more productivity (Figure 1).
Thus, the strain improvement began in 1943 after the isola-
tion of P. chrysogenum NRRL 1951 from a mouldy canta-
loupeinalocalmarketinPeoria,IL,USA[25,26].Thisstrain
was more suitable than P. notatum for penicillin production
in submerged cultures (60μg/mL). Selection of single spores
allowed the isolation of the higher-producing lineage NRRL
1951-B25, which produced up to 150μg/mL (250i.u./mL).
This strain was X-ray treated by Demerec at the Carnegie
Institution (Cold Spring Harbor, NY, USA) giving rise to
the X-1612 mutant, which yielded 300μg/mL of penicillin.
This strain was mutated by 275nm ultraviolet irradiation of
spores at the University of Wisconsin, and the Q-176 mutant
was obtained. It was tested in 300-liter fermentors, yielding
over 550μg/mL (900i.u./mL) [27]. This strain represents the
origin of the Wisconsin family of superior strains, some pro-
ducing over 1800μg/mL (3000i.u./mL) [28]. After ultravio-
let mutagenesis of strain Q-176, the pigmentless strain BL3-
D10wasobtained.Thiswasdesirableduetocommercialpur-
poses, since extraction of the yellow pigment produced nat-
urally by P. chrysogenum gave rise to antibiotic losses during
the puriﬁcation process. Therefore, this strain was selected
to produce directly the white commercial product although
it involved a 25% reduction in penicillin yield [28]. The
BL3-D10 strain was subjected to successive colony selectionJournal of Biomedicine and Biotechnology 3
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Figure 1: Scheme showing the industrial strain improvement pro-
gram of P. chrysogenum,B a r r e i r oe ta l ., 2011.
rounds without mutagenesis to stabilize the mutant strains.
Inthisway,47–638,47–1564,and48–701wereobtained.The
48–701 strain produced around 650μg/mL of penicillin and
was mutated with nitrogen mustard, thus giving rise to the
Wisconsin 49–133 strain. This strain represented the great-
est single improvement among the Wisconsin pigmentless
series, with penicillin yields 100% above that of the 48–701
parent, only 50% as much mycelium, and an “exceptionally
eﬃcient utilization of phenylacetic acid” [29]. After several
steps of nitrogen mustard mutagenesis followed by several
steps of selection and one step of ultraviolet irradiation, the
improved-producer Wisconsin 54–1255 was obtained and
became the laboratory reference strain [23, 30, 31]. Besides
the University of Wisconsin, some companies developed
their own industrial strain improvement programs in order
to obtain penicillin high-producer strains, but few data
are available about these programs. For example, Panlabs
Inc. (Taiwan) started the program with strains P1 and P2,
which are derived from the Q-176 strain [32], DSM (The
Netherlands) developed the DS04825 strain from the Wis-
consin 54–1255 strain [33], Wyeth Lab (West Chester, PA,
USA) developed the M strains (obtained from the Wisconsin
51–20 strain, one of the ancestors of Wisconsin 54–1255),
and Antibioticos S.A. (Spain) produced the AS-P-78, AS-P-
99, and E1 strains from the Wisconsin family [34]( Figure 1).
Overproducer mutants currently used for the industrial pro-
duction of penicillin can reach titers of more than 50mg/mL
(83300 i.u./mL) in fed-batch cultures [32, 35].
As a consequence of the strain improvement programs,
numerous modiﬁcations leading to impressive penicillin tit-
ers were introduced in P. chrysogenum.S o m ew e r e
characterized in detail, such as the phenomenon of ampli-
ﬁcation that occurs in the genomic region containing the
three penicillin biosynthetic genes, pcbAB, pcbC, and penDE
(Figure 2(a)). These genes are arranged in a single cluster
located on a DNA region present as a single copy in the
genome of the wildtype NRRL 1951 and Wisconsin 54–1255
strains. This region undergoes tandem ampliﬁcation in peni-
cillin overproducing strains, giving rise to several copies of
the biosynthetic gene cluster in those strains [34, 36]. Hence,
the AS-P-78 strain was reported to contain 5 to 6 copies, the
E1 strain 12 to 14 copies [34], and the DS0485 strain 5 to
6 copies [37]. The mechanism of gene ampliﬁcation is intri-
guing; it has been suggested that the conserved hexanucleo-
tides located at the borders of the ampliﬁed region may be
hot spots for site-speciﬁc recombination after mutagenesis
[34]. It is noteworthy that the ampliﬁed region contains
other ORFs in addition to the three biosynthetic genes
[37, 38]. Since these ORFs are ampliﬁed together with the
penicillin biosynthetic cluster, a role in penicillin biosyn-
thesis, regulation or secretion might be expected for those
ORFs. However, it was demonstrated that the role of those
ORFs was not essential for penicillin biosynthesis (although
they may contribute to high penicillin production), since the
presence of the three penicillin biosynthetic enzymes alone
was suﬃcient to restore β-lactam synthesis in a mutant lack-
ing the complete region [37, 39]. No penicillin pathway-spe-
ciﬁc regulators have been found in the genome region that
contains the penicillin gene cluster, and the biosynthesis of
this antibiotic is controlled by global regulators, such as
LaeA [40], the velvet complex [41], or StuA [42]. Other
genes encoding enzymes important for the biosynthesis of
penicillin are also absent from the ampliﬁed region. This is
the case of the ppt gene encoding the phosphopantetheinyl
transferase that posttranslationally activates the δ-(L-
α-aminoadipyl)-L-cysteinyl-D-valine synthetase (the ﬁrst
enzyme of the penicillin biosynthetic pathway) [43], or the
phl gene encoding the phenylacetyl-CoA ligase, which acti-
vates the aromatic side chain of benzylpenicillin [44]. Inter-
estingly, the ampliﬁcation of either the laeA, ppt, or phl genes
gave rise to increased penicillin titers [40, 43, 44].
Although high-producing strains contain several copies
of the penicillin cluster, it has been reported that penicillin
production does not follow a linear correlation with the
biosynthetic gene copy number, the transcript, or enzyme
levels [36, 45–47], indicating that other modiﬁcations are
also playing an important role. One of those modiﬁcations
has also been characterized in detail and is related to the
catabolism of phenylacetic acid (the benzylpenicillin side
chainprecursor).Phenylaceticacidisaweakacidthatistoxic
to cells depending on the concentration and the culture
pH. This compound can be metabolized in P. chrysogenum
through at least two routes; incorporation to the benzylpeni-
cillin molecule or catabolism via the homogentisate pathway
[48–51]( Figure 2(b)). The ﬁrst step of the homogentisate
pathway consistsof 2-hydroxylation of phenylacetic acid ring
yielding 2-hydroxyphenylacetate. This reaction is catalyzed
by a microsomal cytochrome P450 monooxygenase (pheny-
lacetic acid 2-hydroxylase; phenylacetate, NAD(P): oxygen
oxidoreductase (2-hydroxylating); EC number 1.14.13),4 Journal of Biomedicine and Biotechnology
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Figure 2: Examples of two well-known modiﬁcations that occurred during the strain improvement program. (a) Ampliﬁcation of the DNA
region containing the penicillin biosynthetic gene cluster in high-producing strains. LEB: left end border; REB: right end border; TRU:
tandem repetition union. (b) Modiﬁcation in the metabolic ﬂuxes through the homogentisate pathway for phenylacetic acid catabolism and
the penicillin biosynthetic pathway. Thickness of arrows indicates the ﬂux rate through a speciﬁc enzyme. α-AAA: α-aminoadipic acid; ACV:
δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine; CoA: coenzyme A; Cys: cysteine; Val: Valine, Barreiro et al., 2011.
which is encoded by the pahA gene. Sequencing of the pahA
gene from several strains of P. chrysogenum revealed that
whereas the wildtype strain (NRRL 1951) contains a C at
position 598 of the gene, the 49–133 strain (and likewise its
descendantWisconsin54–1255)replacesthisnucleotidewith
aT[ 52]. This modiﬁcation in the gene sequence originates
an L181F mutation in the protein, which is responsible for
the reduced function of the enzyme. Therefore, the catabo-
lismofphenylaceticacidthroughthehomogentisatepathway
isdiminishedinWisconsin54–1255and,presumably,inder-
ived strains as well, leading to a reduced degradation of
phenylacetic acid and to penicillin overproduction [52]
(Figure 2(b)). The importance of this enzyme in penicillin
production was also highlighted after the comparative anal-
ysis of the pahA gene of P. notatum (the Fleming’s isolate)
and P. chrysogenum NRRL 1951 (the wildtype strain isolatedJournal of Biomedicine and Biotechnology 5
in Peoria). The latter strain shows a C1357T (A394V) muta-
tioninthisgenethatisconservedinWisconsin54–1255(and
presumably, in derived strains as well). This mutation is res-
ponsible for a loss of function in the phenylacetic acid 2-
hydroxylase, which is directly related to penicillin overpro-
duction and supports the historic choice of P. chrysogenum
as the industrial producer of penicillin [53]. Therefore, the
consecutive accumulation of point mutations in the pheny-
lacetic acid 2-hydroxylase is another reason that made
P. chrysogenum a good penicillin producer.
Adirectrelationbetweenmicrobody(peroxisome)abun-
dance and increased penicillin titers was also observed [54].
Microbodies are organelles involved in the ﬁnal steps of
the penicillin pathway, which are catalyzed by the acyl-co-
enzyme A: isopenicillin N acyltransferase (IAT) and phenyl-
acetyl-CoA ligase [18, 55, 56]. In fact, it has been reported
that microbody volume fractions are enhanced in high-pro-
ducing strains [57]. Compartmentalization of the penicillin
pathway between cytosol and microbodies has been crucial
for productivity. P. chrysogenum seems to have lost its capa-
bility to synthesize penicillins in the cytosol [58], and pero-
xisomesarerequiredforeﬃcientpenicillinbiosynthesis[59].
Inaddition totheseobservations,somemodiﬁcationsre-
mainedhiddenuntilthearrivalofthe“omics”era.Thepubli-
cation of the genome sequence of P. chrysogenum Wisconsin
54–1255[57]representedtheultimatespringboardforsever-
al studies aimed to decipher the genetic secrets of the indus-
trial production of penicillin. Some modiﬁcations that have
been reported are the introduction of a 14bp repeat in
a cephalosporin esterase homolog between Q-176 and Wis-
consin 54–1255 (disturbing the ORF), which suggests a re-
d u c t i o ni nu n w a n t e dβ-lactam degradation, or a mutation in
an ABC transporter homolog between Q-176 and Wisconsin
54–1255, suggesting a change in transport capabilities [60].
Transcriptomics data revealed that expression of genes in-
volved in biosynthesis of the amino acid precursors for peni-
cillin biosynthesis (cysteine, valine, and α-aminoadipic acid)
was higher in the high-producing strains. The same trend
was followed by several genes encoding microbody pro-
teins [57]. Interestingly, the transcription of the penicillin
biosynthesis genes pcbAB, pcbC, and penDE was only two-
to fourfold higher in the high-producing strain [57] sug-
gesting that changes in other metabolic pathways related
to penicillin biosynthesis have contributed as much to
penicillin biosynthesis as the ampliﬁcation of the three direct
biosynthetic genes. Another interesting study dealing with
transcriptomics was carried out by Harris and coworkers
[61]. These authors analysed the expression responses of
P. chrysogenum to the addition of the side-chain precursor
phenylacetic acid and found that the homogentisate pathway
genes, as well as those genes involved in nitrogen and sulfur
metabolism, were upregulated strongly in those cultures
supplemented with the side chain precursor.
Although the above-mentioned reports on genomics and
transcriptomics provided a global overview of some mech-
anisms contributing to increased penicillin production, full
exploitation of P. chrysogenum still required the integration
of other “omics,” such as proteomics. In fact, as we will
show in next sections, the study of the proteome was crucial
to decipher the molecular mechanisms responsible for the
improved productivity of P. chrysogenum.
3.Methodology ofthe IntracellularProtein
ExtractioninP. Chrysogenum
As previously described, the vast knowledge accumulated
along decades about the P. chrysogenum metabolism, and
penicillin production contrasts with the scare information
generated about methodology related with the “omics” ap-
proach, particularly with proteomics. Thus, the most basic
procedures such as good-quality protein extraction for bidi-
mensional analysis should be updated. A bibliographic
searchshowsdiﬀerentproceduresforproteinextraction,pre-
cipitation, or protein solubilization that should be adapted
for P. chrysogenum. These extraction procedures, in the case
of free-living microorganisms, have some common steps,
such as the mechanical breaking, the use of protease inhi-
bitors, reducing agents, and TCA precipitation for intra-
cellular proteomes that help in the protocol update.
Theprocesstoobtaincytoplasmicproteinsshouldinclude
an initial step to discard the media, unbroken mycelia, cell
wall, and membrane contaminants in order to present the
intracellular proteome as clean as possible. Thus, when cul-
tures reach the desired conditions, the most common myce-
lia-collection process is ﬁltration, since centrifugation of
mycelial microorganisms does not generate compact pellets
that make the subsequent washing steps diﬃcult. This pro-
cedure can be done by ﬁltering through a Whatman 3MM
paper (Whatman, Maidstone, England) or nylon ﬁlters (Ny-
tal Maissa, Barcelona, Spain) [62–65]. Hence, mycelia is coll-
ected and washed, and the media can be stored for further
analysis of secreted proteins (Figure 3). Washing steps, which
allow the media elimination that can interfere in the protein
puriﬁcation, are usually done at 4◦C so as to diminish the
protein lysis by intracellular proteases. The most commonly
employed washing solutions are (i) water [64, 66, 67]; (ii)
phosphate buﬀered saline (PBS) [68], or (iii) combination of
0.9% sodium chloride and water [69]. In order to prevent
protein degradation, samples collected at diﬀerent time
points or conditions are washed, paper-dried, and immedi-
ately stored at −20◦Ct o−80◦C for several months.
Regarding the intracellular protein extraction, keeping
the temperature as low as possible and the addition of pro-
tease inhibitors are two common steps included in all the
protocols. Thus, the use of liquid nitrogen to decrease warm-
ing of the disruption systems is a widely used method. The
main breaking system is the traditional prechilled mortar
grinder due to its eﬃciency against the fungal cell wall
[68, 70, 71] although waring blender machines [62], or glass
bead-beating systems, either combined with a 10mM Tris-
HCl buﬀer [72]o rw i t hap h e n o lb u ﬀer [64, 70], have been
successfullyapplied.Afterthebreakingstep,theproteinsolu-
bilization buﬀer always includes a protease inhibitor (e.g.,
protease inhibition cocktail for fungi and yeast (Sigma),
COMPLETE (Roche)) [63, 69], in addition to a reducing
agent (e.g., 2-mercaptoethanol (BME), Dithiothreitol
(DTT)) that reduces the disulﬁde linkages between two6 Journal of Biomedicine and Biotechnology
Power medium
7 days, 28 ◦C
500 mL nonbaﬄed ﬂask
100 mL PMMY medium
(deﬁned)
Nytal ﬁltration
Wash: ·1 ×0.9 % NaCl
·1× ddH2O
Pellet dry (paper)
Conidia
1 plate/ﬂask
Store at 80  ◦C
Bidimensional gel (2D)
Precooled mortar
(liquid N2)
Fine powder
2 g mycelia/10 mL buﬀer (ratio 1 : 5)
[10 mM (K2HPO4 : KH2PO4); 0.07 % DTT;
pH 7.4]. 1 tablet complete/10 mL buﬀer
Shake 2 h, 4  ◦C
20% TCA + 0.14 % DTT (vol:vol). 1h, −20  ◦C
·1 ×80 % acetone
Clarify: 13000 ×  g, 5 min, 4  ◦C
10 mL tube: 3900×  g, 5 min, 4  ◦C
1.5 mL tube: 13000×  g, 5 min, 4  ◦C
Filter 0.45 μm
[8 M urea, 2 % (w/v) CHAPS, 0.5 % (v/v) IPG buﬀer
pH 3–10 nonlinear (NL),
20 mM DTT, 0.002 % bromphenol blue]
Shake 1 h, R/T. store −20◦C
40–68 h 25 ◦C
250 rpm
wash: · ×acetone −20 2 ◦C
Figure 3: Schematic representation of the optimized method for mycelia and secreted proteins collection of P. chrysogenum in order to anal-
yze the intracellular and extracellular proteomes. Green/purple-coloured arrows show the common steps for both methods. Green arrows
represent the speciﬁc method for secreted proteins isolation. Purple arrows show those steps speciﬁc for intracellular proteome isolation,
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cysteines [63, 66]. Frequently, the reducing agent is added
to the precipitation solution (0.093% BME, 0.14% DTT).
This precipitation step (previous to resuspension in sample
solution)isemployedtoselectivelypurifyproteinsfromcon-
taminants such as salts, nucleic acids, detergents, or lipids,
which interfere the ﬁnal bidimensional analysis. Although
the combination of trichloroacetic acid (TCA) and acetone
is usually more eﬀective than either TCA or acetone alone
[73], other mixtures, such as methanol/ammonium acetate,
have been described for fungi [70]. Optionally, a nuclease
mix (0.5mgmL−1 DNase, 0.25mgmL−1 RNase, and
50mmolL−1 MgCl2; or commercially available, for example,
Benzonase (Merck)) can be used as additional treatment
before sample precipitation [68, 74]. When the precipitation
step is omitted, direct solubilization in homogenization buf-
fer is done, which includes fungal DNase/RNase as described
by Oh and coworkers [72].
Proteinsmaybediﬃculttoresolubilizeandmaynotreso-
lubilize completely after TCA precipitation (“2-D Electro-
phoresis. Principles and Methods”; GE Healthcare). Thus,
residual TCA must be removed intensively by cold acetone
washing steps, for example, (i) 2x acetone plus 0.07% DTT
and1x80%acetone[69];(ii)2xacetonecontaining1%BME
[66, 67]; (iii) 3x acetone/0.3% DTT (wt/vol) [70]. A helpful
tip after TCA precipitation and washing is to avoid long dry-
ing periods of time in order to improve protein resuspension
(1-2 minutes is enough). The main components of the ﬁnal
sample buﬀer or homogenization buﬀe rd e s c r i b e di nf u n g a l
bibliography have urea (7–9M), thiourea (0–2M), CHAPS
(1–4% w/v), and ampholyte (0,5–2%) combined as follows:
(i) 8M urea, 2M thiourea, 1% (w/v) CHAPS, 20mm
DTT, and 0,5% (v/v) ampholyte 3–10 [65];
(ii) 8M urea, 2% CHAPS, 20mM DTT, and 0.5% (v/v)
biolytes [63];
(iii) 7M urea, 2M thiourea, 4% CHAPS (w/v), 20mM
DTT, and 1.0% IPG buﬀer (v/v) [67];
(iv) 7Murea,2Mthiourea,4%(w/v)CHAPS,0.8%(v/v)
ampholytes, 20mM Tris, and 20mM DTT [66];
(v) 7M urea, 2M thiourea, 2% (w/v) CHAPS, 1% (w/v)
Z w i t t e r g e n t3 – 1 0 ,a n d2 0m MT r i s[ 70];
(vi) 7M urea, 2M thiourea, 4% (w/v) CHAPS, 1% (w/v)
DTT, 20mM Tris, and 1% (v/v) Pharmalyte pH 3–10
[68];
(vii) 8M urea, 4% CHAPS, 40mM Tris-pH 7.4, 100mM
DTT, and 0.2% ampholyte [72].
A protocol described by Kniemeyer and coworkers [66]
for protein extraction of Aspergillus fumigatus summarized
part of the steps described above, since after the mycelia
homogenization in a pre-cooled (in liquid nitrogen) mortar
they did the extraction, cleaning, and precipitation steps to-
gether, using the Clean-Up kit (GE Healthcare). This pro-
cedure produced quite good results when it was applied to
P. chrysogenum (Figure 4(a)) showing a good protein yield.
However, some problems, such as the poor representation
of large proteins (>75kDa), stripping in the basic region,
andtheimpropercleaningofthemiddle-sizedproteinregion
(50–100kDa), were observed. Notwithstanding the fact that
some problems are described, this procedure can be applied
for fungal protein extraction.
Based on the methods described by Fern´ andez-Acero
and coworkers [63]f o rBotrytis cynera, the mortar grinding
approach combined with a phosphate buﬀer extraction was
used for P. chrysogenum. This method improved the ﬁnal
bidimensional gel results (Figure 4(b)), replacing the lacks
observed in the direct Clean-Up kit method. In addition, this
procedureyieldedlargeproteinamounts,whichallowedblue
silver Coomassie colloidal staining [76], thus simplifying the
2D gels handling.
As a conclusion of the protocols and the experimental
work found in literature, the best protein extraction method
for P. chrysogenum (Figure 3) was the one described in our
laboratory by Jami and coworkers [69], which consisted of
the following.
(i) Filtrate through nylon ﬁlters (Nytal membrane), 1x
0.9% NaCl washing, 2x ddH2O washing, paper dried
a n ds t o r e da t−80◦C.
(ii) Grinding of two grams of mycelia to a ﬁne powder in
a pre-cooled mortar using liquid nitrogen.
(iii) Stirring the homogenized powder at 4◦Cf o r2hi n
10mL (ratio: 1g/5mL) of phosphate buﬀer (10mM
potassium phosphate buﬀer (K2HPO4:KH 2PO4)
(pH 7.4) containing 0.07% (w/v) DTT and supple-
mented with tablets of protease inhibitor mixture
complete (one tablet/10mL of buﬀer)). Clarify by
centrifugation at 13000×g for 5min twice.
(iv) Protein precipitation for 1h at −20◦C after addition
of1volumeof20%TCAinacetonecontaining0.14%
(w/v) DTT. Harvest the protein pellet at 4,000×g,
5m i n u t e sa t4 ◦C. Washing steps: 2x acetone and 1x
80% acetone (salt elimination). Solubilization of the
ﬁnal pellet was done by shaking 1h at room tempera-
ture in 500μLo fs a m p l eb u ﬀer (8M urea; 2% (w/v)
CHAPS; 0.5% (v/v); IPG buﬀer pH 3–10 nonlinear
(NL) (GE Healthcare); 20mM DTT; 0.002% bro-
mophenol blue).
(v) Centrifugation at 13,200rpm for 1min to discard the
insoluble fraction. The supernatant was collected,
and protein concentration was determined according
to the Bradford method [77].
As a result of the protein extraction method optimiza-
tion, an interactive reference map suitable for protein loca-
tion of P. chrysogenum Wisconsin 54–1255 (reference
strain) was uploaded at the website: http://isa.uniovi.es/
P chrysogenum proteome/.
4. IndustrialStrain Evolution of
P. chrysogenum from
the Proteomics Point of View
Theevolutionofthepenicillinproducerstrains,aspreviously
described (Section 2), has been a complex process of random8 Journal of Biomedicine and Biotechnology
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Figure 4:OptimizationoftheproteinextractionprotocolfrommyceliaofP. chrysogenum.(a)Extractionandpuriﬁcationofproteinsamples
with “Clean-Up Kit” (GE Healthcare), based on Kniemeyer and coworkers [66] and silver stained. As sample buﬀer was used, 7M urea, 2M
thiourea, 4% (w/v) CHAPS, 0.8% (v/v) IPG buﬀer pH 3–10 nonlinear (NL) (GE Healthcare), 40mM Tris, 1mM EDTA, and 20mM DTT
[75]. (b) The extraction is based on the method described by Fern´ andez-Acero and coworkers [63] by using mortar gridding and phosphate
buﬀer, plus blue silver Coomassie colloidal staining [76]. As sample buﬀer was used, 8M urea, 2% (w/v) CHAPS, 0.5% (v/v) IPG buﬀer
pH 3–10 NL (GE Healthcare), 20mM DTT, and 0.002% bromophenol blue [69]. Precision plus protein standards (Bio-Rad) were used
as markers. The molecular mass is indicated in kilo-Daltons (kDa). Note the problematic regions observed with the extraction method A,
which are highlighted by arrowed square brackets (left and bottom), Barreiro et al., 2011.
mutagenesis and further screening. This system accumulates
beneﬁcial unknown mutations, which increased the ﬁnal
titers of penicillin, but does not provide clues about the
modiﬁed genes or proteins. The recent application of pro-
teomic techniques has allowed the identiﬁcation of several of
these modiﬁcations, which opens the option for the genome
breeding approach to fungi following the steps developed in
other microorganisms [78]. Along the strain improvement
process, several metabolic pathways have been redirected to
obtain (i) more precursors, (ii) energy-supplying molecules
for the penicillin synthesis in parallel to (iii) decrease in
virulence or pigment production (Figure 5). Comparison
among three diﬀerent strains of P. chrysogenum: (i) NRRL
1951 (wildtype strain), (ii) Wisconsin 54–1255 (model
strain; moderate production), and (iii) AS-P-78 (high-pro-
ducing strain) showed a clear picture of the industrial im-
provements [69]( Figure 1). Thus, the three precursor amino
acids (L-α-aminoadipic acid, L-cysteine and L-valine) in-
volved in the nonribosomal condensation, which is the ini-
tial step of penicillin synthesis, presented a decrease of their
catabolic pathways: (i) cysteine catabolism (cystathionine
β-synthase); (ii) valine catabolism (methylmalonate-semi-
aldehyde dehydrogenase); (iii) fatty acid degradation (phy-
tanoyl-CoA dioxygenase family protein) and an increase of
their biosynthetic pathways involved in the penicillin syn-
thesis: (i) cysteine synthesis (cysteine synthase), (ii) valine
synthesis (branched-chain amino acid aminotransferase),
and (iii) branched amino-acid synthesis (dihydroxy-acid
dehydratase). Surprisingly, the high-producer strain (AS-P-
78) does not present a signiﬁcant overrepresentation of the
proteins directly involved in the penicillin production, des-
pite the fact that AS-P-78 contains ﬁve or six copies of the
ampliﬁed region that includes the penicillin biosynthetic
genes [34, 38] (see Section 2). Similar results were obtained
with transcriptomic analysis using other high-producing
strains [57]. In fact, the lack of a linear relationship between
the number of copies of the penicillin gene cluster and the
penicillin titers was previously observed [36]. In summary,
it was concluded that penicillin gene cluster ampliﬁcation
is not the main mechanism that transformed the wildtype
strain (NRRL 1951) into a penicillin overproducer (AS-P-
78), even when it had a clear impact on production.
The penicillin titers are also increased in high-producing
strains by the downregulation of penicillin modiﬁcation or
degradation-related proteins, such as an esterase, which con-
tains a β-lactamase domain possibly involved in penicillin
degradation.Besides,thereareproteinsinvolvedinothersec-
ondarymetaboliteproductionpathwaysunderrepresentedin
the high-producing strain, which decreased their expres-
sion throughout industrial strain evolution. A 3-hydroxy-
3-methylglutaryl-CoA synthase and a coproporphyrinogen
oxidase III involved in terpenoid synthesis and porphyrin
metabolism, respectively, are clear examples of this redirec-
tion of metabolism [69].
The wildtype strain (NRRL 1951) presents a variety of
proteins involved in pigment formation, in agreement withJournal of Biomedicine and Biotechnology 9
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the well-known ability of this strain to synthesize large
amounts of pigment, which decreased or disappeared in the
industrial strains. Thus, a zeaxanthin epoxidase involved in
naturalxanthophyllpigmentproductionis11-folddownrep-
resented in the AS-P-78 strain, and a scytalone dehydratase
(involved in the biosynthesis of melanin protecting hyphae
and spores from UV light, free radicals, and desiccation in
addition to serving as a virulence factor [79]) is only present
in the wildtype strain. As it was mentioned above, during
the mutagenic treatments (from Q-176 to BL3-D10 strains),
pigmentless strains were selected (Figure 1).
The analysis of the cytoplasmatic proteome has also
shown a rearrangement of the internal energetic ﬂuxes
through the glycolysis and pentose phosphate pathways to
the penicillin biosynthetic pathway, which constitutes a ma-
jor burden on the supply of NADPH. In the one hand, the
AS-P-78 (high production) strain overproduces enzymes of
the pentose phosphate pathway like ribose-5-phosphate iso-
meraseortransketolase[69].Itislikelythatahighconcentra-
tion of ribulose 5-phosphate, together with reducing power
in the form of NADPH, is formed in the high-producer
strain. Thus, this sugar phosphate excess is converted by the
ribose-5-phosphate isomerase into ribulose 5-phosphate
(precursor of nucleic acids and nucleotides) and glycolysis
precursors by the transketolase, which connects both meta-
bolic pathways (pentose phosphate and glycolysis) [69]. On
the other hand, the NADPH level is strongly correlated to
β-lactam production (8–10mol of NADPH are required for
the biosynthesis of 1mol of penicillin) [80]. In addition, the
ATP level and cysteine concentration have been reported to
have a great inﬂuence over the penicillin production [81].
Because NADPH is required for cysteine biosynthesis, a pos-
itive relationship among cysteine, NADPH levels, and peni-
cillin production can be established [81]. In addition, the
increase in cysteine biosynthesis could be also related to an
increased demand for glutathione biosynthesis to cope with
higher levels of the oxidative stress related to high aeration
rates in the high penicillin producer strain. Besides, the oxi-
dized glutathione during oxidative stress requires NADPH
to reduce it. Therefore, the connection between NADPH,
oxidative stress, and pentose phosphate pathway has been
well established by means of the proteomics approach in P.
chrysogenum [69]( Figure 5).
In concordance with the underrepresentation of the pro-
teins involved in pigment formation, as well as other second-
ary metabolites in the high-producer strains (less energy
consumption), the proteins involved in virulence are also
underrepresented. This situation has been observed with10 Journal of Biomedicine and Biotechnology
aglucoseoxidase,whichhasbeendescribedasinvolvedinthe
pathogenicity of Penicillium expansum in apples [82]a n d
with a host infection protein (Cap20), which plays a signif-
icant role in the fungal virulence on avocado and tomato
fruits [83]. Besides, UDP-galactopyranose mutase involved
in galactofuranose biosynthesis, which plays a crucial role
in cell envelope formation and the infectious cycle [84],
is downrepresented in the high-producer strain AS-P-78.
Therefore, the decrease of proteins involved in virulence and
plant cell wall degradation through the strain evolution is
substantiated by the specialization on industrial raw material
consumption by the mutagenized strains.
In summary, the proteomics approach through the intra-
cellular proteome analysis has added more relevant informa-
tion about the events that led to create “domesticated”
strains, which are the current high penicillin producer
strains.
5.How toGuaranteetheSecretomeQuality?
Even when the analysis of the extracellular proteome does
not suggest a clear relation with the antibiotics production in
P. chrysogenum,i tc a no ﬀer new clues either for the general
understanding of the fungal metabolism or for possible in-
dustrial applications of the secreted proteins. This is the case
ofothersecretedfungalproteinsasthoseofAspergillusoryzae
or Aspergillus niger, which are involved in the production of
fermented foods and beverages or used for the production of
organic acids, food ingredients, and industrial enzymes, res-
pectively [85, 86]. In addition, white rot fungi (the degra-
dation of hemicelluloses and lignin by basidiomycetes and
ascomycetes)andbrownrotfungi(theattackofcelluloseand
hemicelluloses, exclusively, accomplished by basidiomyce-
tous) are involved in the degradation of lignocelluloses,
which represent the world’s largest renewable carbon source
[87]. This huge biomass coming from plant primary meta-
bolism, which is about 140 billion tons annually [88], is pro-
posedasapossiblesubstituteofthelimitedavailabilityoffos-
sil fuels and can be utilized easily and bioconverted with the
help of fungal white biotechnology.
The most crucial step for the secreted protein analysis is
todistinguishtheproteinsreallysecretedfromthosecontam-
inant proteins coming from cell lysis events. This capital pro-
cess can be tackled sequentially from three diﬀerent points
of view: (i) sample collection; (ii) post-identiﬁcation protein
analysis; (iii) “moonlighting proteins” and unconventional
secreted protein analysis.
Some tips in the collection of secreted protein are shown
in Figure 3, such as the intensive mycelia elimination process
(the use of nylon ﬁlters, rigorous centrifugation, and ﬁltra-
tion through 0.45μm ﬁlters) or the use of low temperatures
to avoid mycelia degradation. Sample collection is also cru-
cial to discard those non-natural secreted proteins. It is des-
cribedinthescientiﬁcliteraturehowthepresenceofextracel-
lular proteins in the culture medium is correlated directly to
the growth phase [89]. Jami and coworkers [90] showed the
linear correlation existing between the presence of proteins
in the culture medium and the culture growth (biomass
formation). Interestingly, the increase in the amount of pro-
teinsthatwerepresentintheculturemediumcontinuedeven
after the culture reached the stationary phase. One explana-
tion is that some of those proteins were present in the cul-
ture medium as a result of cell lysis events. Consequently, the
sample uptake should be done at an early time point, but
coincident with a moment of optimal extracellular protein
secretion. For example, P. chrysogenum does not show signi-
ﬁcant amounts of secreted proteins before 24 hours [90].
Related to the post-identiﬁcation protein analysis, the
comparison between secreted proteins at 68h versus those
secreted at 40h in P. chrysogenum was done as an additional
control [90]. It was seen that the expression diﬀerences ob-
served during the time course were mainly due to the pre-
sence at 40h of isoforms from lately expressed proteins and
to proteins expressed only at late stages. As a conclusion, the
amount of possible contaminant intracellular proteins in
the secretome was reported to be very low (6.09%) in
P. chrysogenum [90]. When the intracellular proteome is
known, the presence of contaminant proteins due to cell lysis
canbetestedbythepresenceofintracellularhigh-abundance
proteins. Thus, malate dehydrogenase and glyceraldehydes-
3-phosphate dehydrogenase in Botrytis cinerea or the
ﬂavohemoglobin and manganese superoxide dismutase in
P. chrysogenum should be detected in the case of lysis events,
since these are the most abundant intracellular proteins [69,
91]. However, sometimes it is diﬃcult to ascertain whether
a protein is secreted truly or is present in the culture medium
as a consequence of cell lysis. Recently, new bioinformatics
tools have been developed to characterize the secreted pro-
teins either in a classical or non-classical way by means of
prediction of secretion signal motifs. SignalP (for classical
secretionsignalmotifs)andSecretomeP(fornonclassicalsig-
nal motifs) are useful prediction softwares [92, 93] that can
be used for such purpose. The availability of several fungal
genomes in databases together with the use of those pre-
diction programs for secretory proteins has allowed the
recentdevelopmentofplatformsfortheannotationoffungal
secretomes, such as the Fungal Secretome Database [94]o r
the Fungal Secretome KnowledgeBase (FunSecKB [95]),
which allow the proper identiﬁcation of secreted proteins.
Even when the above-mentioned information is taken
into account and you have the certainty of working with
secreted proteins, some unconventional proteins, dubbed
“moonlighting proteins” [96], can be detected. These pro-
teins present unconventional protein secretion systems [97–
99], and then, it is diﬃcult to deﬁne their authenticity as
secreted proteins. One meaning of moonlighting, according
to The Compact Oxford English Dictionary [100], is “to
do paid work, usually at night, in addition to one’s regular
employment”; therefore, “moonlighting proteins” is a quite
appropriate designation for the collective of multifunctional
proteins, which are widespread among organisms ranging
from bacteria to mammals [101]. In spite of this ubiquity,
more attention has been traditionally given to the “moon-
lighting proteins” found in higher eukaryotes, but recently
the yeasts have caught the attention for lower eukaryotes
[101, 102]. Thus, in many cases, the fusion of two genes
that initially encoded proteins with single functions has beenJournal of Biomedicine and Biotechnology 11
the origin of that duality. On the other hand, a signiﬁcant
number of proteins can perform dissimilar functions [101,
102].
Another phenomenon that has been observed in the
P. chrysogenum secretome is the fact that some extracellular
proteins identiﬁed in the reference map were also identiﬁed
previously by Kiel and coworkers [103] in the microbody
matrix of this fungus. Therefore, an alternative explanation
given to the presence of intracellular proteins in the culture
broth was the selective autophagic degradation of peroxi-
somes(pexophagy),whichcangiveanewsensetothestrange
“moonlighting proteins” as we explained in P. chrysogenum
[90]. It is well known that peroxisome abundance can be
decreasedrapidlythroughautophagicpathways,whichselec-
tively degrade peroxisomes by fusion to lysosomes or vac-
uoles [104]. Integration of peroxisomes into vacuoles may
lead to secretion of the proteins located in the peroxisomal
matrix by exocytosis, a mechanism that has been discussed
as an alternative route for the release of penicillin from per-
oxisomes to the culture medium [18].
Taking into account all these factors, the analysis of the
extracellular proteome of P. chrysogenum has been complet-
ed fully [90]. It can be consulted in an interactive way by
means of the reference map present at the website: http://isa.
uniovi.es/P chrysogenum secretome/.
6.Penicillium chrysogenum:AV e rsatileC ell
Factory for Biotechnology
Genome sequence of P. chrysogenum revealed the presence of
several nonribosomal peptide synthetases (NRPSs), polyke-
tide synthases (PKSs), and hybrid NRPS-PKS enzymes [57],
highlighting the potential of this microorganism to produce
other secondary metabolites diﬀerent from penicillin. Even
more interesting than the production of homologous sec-
ondary metabolites is the potential use of P. chrysogenum as
a host for the biosynthesis of heterologous secondary meta-
bolites. In fact, due to the good metabolic ﬂuxes of the peni-
cillinbiosyntheticpathway,P. chrysogenum wasengineeredto
produce cephalosporin intermediates [105–107]. The avail-
able information about fermentation conditions and opti-
mization of P. chrysogenum to industrial conditions has pro-
motedthedevelopmentofhoststrainsthatlackthepenicillin
gene cluster [61, 108], which could be optimal for the pro-
duction of heterologous metabolites.
In addition to secondary metabolites, secreted enzymes
also reﬂect the versatility of P. chrysogenum. The analysis of
the secretome of this fungus [90] has also suggested the
potential interest of nonpenicillin producer strains for other
biotechnological uses, such as food and beverage indus-
tries. Some proteins identiﬁed in the culture medium of
P. chrysogenum are of interest for this biotechnological area.
This is the case of a probable isoamyl alcohol oxidase, an
extracellular enzyme in A. oryzae catalyzing the formation of
isovaleraldehyde, which is the main component of mureka
that gives sake an oﬀ-ﬂavor [109]. Another example is sul-
phydryl oxidase, which may be used for treatment of bakery
products or for removal of oﬀ-ﬂavour from UHT-treated
milk or beer [110]. A relevant enzyme for its application in
food industry is dihydroxy-acid dehydratase, which removes
vicinal diketones. These compounds are responsible for the
oﬀ-ﬂavor of diacetyl (butter ﬂavor or sweaty ﬂavor in beer,
“tsuwari-ka,” or nauseating ﬂavor in sake) in brewed alco-
holic beverages. Overproduction of dihydroxy-acid dehy-
dratase in S. cerevisiae has been patented to produce alco-
holic beverages with superior ﬂavor [111]. It is also impor-
tant the secretion of a prolyl aminopeptidase during the
ripening of the Camembert cheese since it decreases the
amount of bitter tasting peptides [112]. Other proteins, such
as pectinolytic enzymes, which play an important role in
beverage and juice industries, were also found in the secre-
tome of P. chrysogenum. Additional relevant secreted enzy-
mes are ferulic acid esterases, which release ferulic acid (a
naturally occurring hydroxycinnamic acid derivative with
beneﬁcial medical eﬀects [113]) from plant cell walls. It has
been proposed that ferulic acid esterases have the ability not
only to degrade plant biomasses, but also to synthesize novel
bioactive components [114].
Although there are other systems for the production of
useful proteins, such as bacteria, insects, mammalian cell
culture, transgenic animal, plant cell cultures, and transgenic
plants,theversatilityofP. chrysogenum,itsplasticity,itsabili-
ty to grow on diﬀerent media and conditions, and the avail-
ability of several mutants and tools for its genetic manipu-
lation may confer some advantages on P. chrysogenum over
othersystemstoproduceandsecretehighamountsofhomo-
logous and heterologous proteins.
7. Concluding Remarks
The new “omics” era has allowed scientists, 80 years after the
Fleming’s fortuitous discovery of the penicillin-producing
fungus Penicillium notatum, to start to comprehend the
molecular basis of the eﬀect of six decades of classical strain
improvement. Besides, the advances in microbiology, bio-
chemistry, genetics, and molecular biology have contributed
to the knowledge of structural, ancillary, and regulatory
biosynthetic genes and enzymes, together with the charac-
terization of the subcellular compartments involved in the
biosynthesis of β-lactam antibiotics. Therefore, genomics,
transcriptomics, proteomics, metabolomics, and ﬂuxomics
studies have revealed that major modiﬁcations in primary
and secondary metabolism (phenylacetic acid catabolism,
peroxisome biogenesis, pentose phosphate pathway, redox
metabolism, biosynthesis of precursor amino acids, peni-
cillinbiosynthetic enzymes,etc.)occurredduringtheimpro-
vement programs, rebalancing several cellular processes that
led to the impressive penicillin production reached by the
current industrial strains. As conclusion, these ﬁndings will
help the scientiﬁc community from industry and acade-
mia not only to continue the exploitation of the success-
ful synergy existing between P. chrysogenum and β-lac-
tamantibioticproduction,butalsotoexploretheproduction
of other compounds using this versatile fungus as a cell
factory.12 Journal of Biomedicine and Biotechnology
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